lobbying_activities: 2190810

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2190810	c8162bb2-41a6-4e7b-b34f-766e71e77bff	Q3	WILLIAMS AND JENSEN, PLLC	41454	SANOFI, U.S.	2018	third_quarter	HCR	General education about federal policies impacting pharmaceutical development, approval, and reimbursement (including Medicare, Medicaid, Affordable Care Act issues). Policies impacting public health preparedness and prevention. Pandemic All Hazards Preparedness Authorization Act of 2018, S. 2852. Over-the-Counter Drug Safety Innovations and Reform Act, S. 2315. H.R. 6 Support for Patients and Communities Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2018-10-18T11:32:29.210000-04:00